ADARx Pharmaceuticals, Inc.

ADARx Pharmaceuticals, Inc. (ADRX) priced its initial public offering on Sep 28, 2026 at $17.00 per share, within its $15.00–$17.00 range, raising $446.2M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.82B. Cooley advised the company and Latham & Watkins advised the underwriters.

Status

IPO

Ticker

ADRX

Exchange

Nasdaq Global Select

Priced

Sep 28, 2026

IPO price

$17.00

Price range

$15.00–$17.00

Raised

$446.2M

Market cap at IPO price

$1.82B

First filed

Sep 4, 2026

Company counsel

Cooley

Underwriters' counsel

Latham & Watkins

Sector

Biotech & pharma

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.